FDA Announces Possible Safety Concern for HIV Drug Combination – The U.S. Food and Drug Administration announced preliminary data suggesting that Invirase (saquinavir) in combination with Norvir (ritonavir) may have potentially important adverse effects on the heart.
Landmark heart treatment study — Atrial fibrillation treatment with catheter shows better results than drug therapy – Treating a common heart rhythm disorder by burning heart tissue with a catheter works dramatically better than drug treatments, according to a landmark study published in the Jan. 27 issue of the Journal of the American Medical Association (JAMA).
Dabigatran vs. warfarin as long-term anticoagulant therapy in atrial fibrillation – The anticoagulant dabigatran is more effective than warfarin in the prevention of stroke in patients with atrial fibrillation, revealed by researchers in a study RE-LY (Randomized Evaluation of Long-term anticoagulant therapY).
U.S. Food and Drug Administration (FDA) Approves Sanofi’s Multaq dronedarone to Treat Heart Rhythm Disorders – The U.S. Food and Drug Administration has approved Sanofi’s Multaq tablets (dronedarone) to help maintain normal heart rhythms in patients with a history of atrial fibrillation or atrial flutter (heart rhythm disorders or arrhythmia).
Women with chest pain less likely then men to get proper treatment from paramedics – Penn study shows gender disparities in pre-hospital care. – Women with chest pain are less likely than male patients to receive recommended, proven therapies while en route to the hospital, according to new research from the University of Pennsylvania School of Medicine.
Heart disorder atrial fibrillation linked to Alzheimer’s disease dementia. Study of more than 37,000 patients shows relationship between atrial fibrillation and development of Alzheimer’s disease. – Researchers at Intermountain Medical Center in Salt Lake City believe that they have made a breakthrough connection between atrial fibrillation, a fairly common heart rhythm disorder, and Alzheimer’s disease, the leading form of dementia among Americans.
Feeling down and out could break your heart, literally. Research links depression to cardiac death in women without known heart disease. – Relatively healthy women with severe depression are at increased risk of cardiac events, including sudden cardiac death (SCD) and fatal coronary heart disease (CHD).
Older adults at high risk for drug interactions. More attention needed for non-prescription meds. – At least one in 25 older adults, about 2.2 million people in the United States, take multiple drugs in combinations that can produce a harmful drug-drug interaction, and half of these interactions involve a non-prescription medication, researchers from the University of Chicago Medical Center report in the Dec. 24/31, 2008, issue of JAMA.
The U.S. Food and Drug Administration (FDA) has notified manufacturers of fluoroquinolone antimicrobial drugs that a Boxed Warning in the product labeling concerning the increased risk of tendinitis and tendon rupture is necessary. – The U.S. Food and Drug Administration (FDA) requests boxed warnings on fluoroquinolone antimicrobial drugs. FDA seeks this to strengthen warnings concerning increased risk of tendinitis and tendon rupture.
Special issue of JACC features intriguing link between statins and Atrial Fibrillation (AF) prevention, tools to ensure the highest-quality AF care, and more. – When we’re young, a racing heart often means love is in the air. If you’re a “baby boomer,” it might mean you’ve just joined the 2.2 million Americans who have atrial fibrillation (AF), an irregularity in the heart’s rhythm that grows more common as we age and markedly increases the risk for stroke.